Synapse Open Synapse
Biology

Enveda, an AI drugmaker, banks $311M in venture funding

BioPharma Dive · · 2 min read

Enveda, which is using AI tools to mine plants and microbes for drug prospects, has three candidates in human testing for immune diseases and obesity.

Latest from BioPharma Dive